ALPACA (J3L-MC-EZEB) (Completed) LY3473329 Lp(a) siRNA (subcutane) for secondary MACE prevention in patients with elevated Lp(a) Medicine LY3819469 Lp(a) siRNA (subcutaan) Population ASCVD Phase II Starting year 2022 Publicaties ALPACA (J3L-MC-EZEB) Director of Study dr. M.F.L. Meijs (Cardioloog) Enschede, Medisch Spectrum Twente
